Aptamers are short strands of nucleic acids (DNA or RNA) that bind specifically and strongly to target molecules, making them ...

Columbus, Ohio-based start-up Basking Biosciences has raised $55 million in an unspecific round that will be used to fund a phase 2 trial of BB-031, described as a first-in-class RNA aptamer ...

and Gregory et al have adapted the technology to create an RNA-based probe for use in MND. In time, the hope is that the aptamer could potentially be used not only to look for the biomarker in ...

Prior to joining as Biophysics Director in 2022, she was Team Leader, Senior Scientist in Biophysics in another European CRO and Biotech working on fragments, small-molecules, antibodies and ...

Following the success of the COVID-19 vaccines, mRNA vaccines have now entered development for a wide range of infectious diseases. This Review discusses mRNA vaccine design considerations ...

Background: Previous studies have demonstrated that naringenin possesses lipid-lowering effects; however, the underlying mechanisms, particularly its specific molecular targets, remain uncertain.